Could cheese be the missing piece in the French paradox puzzle?

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 746-749

  Petyaev, Ivan M ^a   Bashmakov, Yuriy K ^a  

^a Lycotec Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDRASTIN A; ANDRASTIN B; ANDRASTIN C; ANDRASTIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; FUNGAL PROTEIN; INTERLEUKIN 6; LIPOPROTEIN; PROBIOTIC AGENT; RESVERATROL; ROQUEFORTINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BLOOD RHEOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CHEESE; CHEESE RIPENING; CHOLESTEROL SYNTHESIS; DIETARY INTAKE; ENZYME INHIBITION; EPIDEMIOLOGICAL DATA; FAT INTAKE; FRENCH PARADOX; HUMAN; INCIDENCE; INFLAMMATION; LIFESTYLE; LIPID BLOOD LEVEL; MOULD; PENICILLIUM ROQUEFORTI; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; RED WINE; TEMPERATURE;

CARDIOVASCULAR DISEASES; CHEESE; DIET; FERMENTATION; FRANCE; HUMANS; MODELS, THEORETICAL;

BACTERIA (MICROORGANISMS); FUNGI; PENICILLIUM ROQUEFORTII;

EID: 84869096917     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.08.018     Document Type: Article

References (49)

1. Black S. Clinical and pathological reports 1819, Alex Wilkinson, Newry, UK, p. 1-47.
2. Law M., Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ 1999, 318(7196):1471-1476.
3. Lippi G., Franchini M., Favaloro E.J., Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin Thromb Hemost 2010, 36(1):59-70.
4. Wu J.M., Hsieh T.C. Resveratrol: a cardioprotective substance. Ann NY Acad Sci 2011, 1215:16-21.
5. Drewnowski A., Henderson S.A., Shore A.B., Fischler C., Preziosi P., Hercberg S. Diet quality and dietary diversity in France: implications for the French paradox. J Am Diet Assoc 1996, 96(7):663-669.
6. Elisha B., Guebre-Egziabher F., Vidal H., Bastard J.P., Laville M., Rabasa-Lhoret R. From French to Mediterranean diet: importance of the omega-6/omega-3 fatty acids ratio. World Rev Nutr Diet 2011, 102:81-91.
7. Nadtochiy S.M., Redman E.K. Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols. Nutrition 2011, 27(7-8):733-744.
8. Tabernero M., Venema K., Maathuis A.J., Saura-Calixto F.D. Metabolite production during in vitro colonic fermentation of dietary fiber: analysis and comparison of two European diets. J Agric Food Chem 2011, 59(16):8968-8975.
9. Pettinger C., Holdsworth M., Gerber M. Meal patterns and cooking practices in Southern France and Central England. Public Health Nutr 2006, 9(8):1020-1026.
10. Perrin A.E., Dallongeville J., Ducimetière P., Ruidavets J.B., Schlienger J.L., Arveiler D., et al. Interactions between traditional regional determinants and socio-economic status on dietary patterns in a sample of French men. Br J Nutr 2005, 93(1):109-114.
11. Tamers S.L., Agurs-Collins T., Dodd K.W., Nebeling L. US and France adult fruit and vegetable consumption patterns: an international comparison. Eur J Clin Nutr 2009, 63(1):11-17.
12. Opie L., Lamont K., Lecour S. Wine and heart health: learning from the French paradox. SAHeart 2011, 8:172-177.
13. Razanamahefa L., Lafay L., Oseredczuk M., Thiébaut A., Laloux L., Gerber M., et al. Dietary fat consumption of the French population and quality of the data on the composition of the major food groups. Bull Cancer 2005, 92(7):647-657.
14. Volatier J.L., Verger P. Recent national French food and nutrient intake data. Br J Nutr 1999, 81(Suppl. 2):S57-S59.
15. Berry E.M., Arnoni Y., Aviram M. The Middle Eastern and biblical origins of the Mediterranean diet. Public Health Nutr 2011, 14(12A):2288-2295.
16. Bondia-Pons I., Serra-Majem L., Castellote A.I., López-Sabater M.C. Identification of foods contributing to the dietary lipid profile of a Mediterranean population. Br J Nutr 2007, 98(3):583-592.
17. Welland D. Make room for cheese - if incorporated wisely, it can be part of a healthful diet. Today's Dietitian 2011, 13(2):16-18.
18. Wielicka A., Gorynska-Goldman E. World and Poland per capita cheese consumption. Rocz AR Pozn CCCLXVII, Ekon 2005, 4:157-166.
19. Morowitz H.J. Killer cheese. Hosp Pract 1992, 27(1):25-29.
20. Kliem K.E., Givens D.I. Dairy products in the food chain: their impact on health. Annu Rev Food Sci Technol 2011, 2:21-36.
21. Crichton G.E., Howe P.R., Buckley J.D., Coates A.M., Murphy K.J. Dairy consumption and cardiometabolic health: outcomes of a 12-month crossover trial. Nutr Metab (Lond) 2012, 20(9):19.
22. Huth P.J., Park K.M. Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv Nutr 2012, 3(3):266-285.
23. Hauswirth C.B., Scheeder M.R., Beer J.H. High omega-3 fatty acid content in alpine cheese: the basis for an alpine paradox. Circulation 2004, 109(1):103-107.
24. Hauswirth C.B., Scheeder M.R., Beer J.H. Alpine cheese-healthy for your heart or just a lifestyle product?. Ther Umsch 2005, 62(9):619-624.
25. Dalmeijer G.W., Struijk E.A., van der Schouw Y.T., Soedamah-Muthu S.S., Verschuren W.M., Boer J.M., et al. Dairy intake and coronary heart disease or stroke - a population-based cohort study. Int J Cardiol 2012, [Epub ahead of print].
26. Goldbohm R.A., Chorus A.M., Galindo Garre F., Schouten L.J., van den Brandt P.A. Dairy consumption and 10-y total and cardiovascular mortality: a prospective cohort study in the Netherlands. Am J Clin Nutr 2011, 93(3):615-627.
27. Usinger L., Jensen L.T., Flambard B., Linneberg A., Ibsen H. The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension. J Hum Hypertens 2010, 24(10):678-683.
28. Pampaloni B., Bartolini E., Brandi M.L. Parmigiano Reggiano cheese and bone health. Clin Cases Miner Bone Metab 2011, 8(3):33-36.
29. Scherr C., Ribeiro J.P. Fat content of dairy products, eggs, margarines and oils: implications for atherosclerosis. Arq Bras Cardiol 2010, 95(1):55-60.
30. Ivey K.L., Lewis J.R., Hodgson J.M., Zhu K., Dhaliwal S.S., Thompson P.L., et al. Association between yogurt, milk, and cheese consumption and common carotid artery intima-media thickness and cardiovascular disease risk factors in elderly women. Am J Clin Nutr 2011, 94(1):234-239.
31. Hjerpsted J., Leedo E., Tholstrup T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr 2011, 94(6):1479-1484.
32. Sofi F., Buccioni A., Cesari F., Gori A.M., Minieri S., Mannini L., et al. Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutr Metab Cardiovasc Dis 2010, 20(2):117-124.
33. Franc M., Krízek T., Coufal P., Stulík K. Differentiation among various kinds of cheese by identification of casein using HPLC-chip/MS/MS. J Sep Sci 2010, 33(16):2515-2519.
34. Dherbécourt J., Bourlieu C., Maillard M.B., Aubert-Frogerais L., Richoux R., Thierry A. Time course and specificity of lipolysis in Swiss cheese. J Agric Food Chem 2010, 58(22):11732-11739.
35. Hinrichs J. Mediterranean milk and milk products. Eur J Nutr 2004, 43(Suppl. 1):I/12-I/17.
36. Karlshøj K., Nielsen P.V., Larsen T.O. Differentiation of closely related fungi by electronic nose analysis. J Food Sci 2007, 72(6):M187-M192.
37. Muro Urista C., Álvarez Fernández R., Riera Rodriguez F., Arana Cuenca A., Téllez Jurado A. Review: production and functionality of active peptides from milk. Food Sci Technol Int 2011, 17(4):293-317.
38. Torres-Llanez M.J., González-Córdova A.F., Hernandez-Mendoza A., Garcia H.S., Vallejo-Cordoba B. Angiotensin-converting enzyme inhibitory activity in Mexican Fresco cheese. J Dairy Sci 2011, 94(8):3794-3800.
39. Phelan M., Kerins D. The potential role of milk-derived peptides in cardiovascular disease. Food Funct 2011, 2(3-4):153-167.
40. Panagiotakos D.B., Pitsavos C.H., Zampelas A.D., Chrysohoou C.A., Stefanadis C.I. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: the ATTICA study. J Am Coll Nutr 2010, 29(4):357-364.
41. Geurts L., Everard A., le Ruyet P., Delzenne N.M., Cani P.D. Ripened dairy products differentially affect hepatic lipid content and adipose tissue oxidative stress markers in obese and type 2 diabetic mice. J Agric Food Chem 2012, 60(8):2063-2068.
42. EL-Sheikh M.M., El-Senaity M.H., Youssef Y.B., Shahein N.M., Abd Rabou N.S. Effect of ripening conditions on the properties of blue cheese produced from cow's and goat's milk. J Am Sci 2011, 7(1):485-490.
43. Nielsen K.F., Dalsgaard P.W., Smedsgaard J., Larsen T.O., Andrastins A-D Penicillium roqueforti metabolites consistently produced in blue-mold-ripened cheese. J Agric Food Chem 2005, 53(8):2908-2913.
44. Fernández-Bodega M.A., Mauriz E., Gómez A., Martín J.F. Proteolytic activity, mycotoxins and andrastin A in Penicillium roqueforti strains isolated from Cabrales, Valdeón and Bejes-Tresviso local varieties of blue-veined cheeses. Int J Food Microbiol 2009, 136(1):18-25.
45. Aninat C., Hayashi Y., André F., Delaforge M. Molecular requirements for inhibition of cytochrome p450 activities by roquefortine. Chem Res Toxicol 2001, 14(9):1259-1265.
46. Lorey T., Poutet P. The representations of wine in France from generation to generation: a dual generation gap. Int. J. Entrepreneurship Small Bus 2011, 13:162-180.
47. Müller-Nordhorn J., Binting S., Roll S., Willich S.N. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008, 29(10):1316-1326.
48. Vollset S.E. Does the Southern European cardiovascular mortality advantage extend to total mortality? 50-year trends in death risks between 40 and 70years of age in Western European men and women. Scand J Public Health 2010, 38(Suppl. 5):127-134.
49. Uchida R., Shiomi K., Inokoshi J., Sunazuka T., Tanaka H., Iwai Y., et al. New protein farnesyltransferase inhibitors produced by Penicillium sp. FO-3929. II: structure elucidation and biosynthesis. J Antibiot (Tokyo) 1996, 49(5):418-424.